Resuscitation Plus (Jun 2024)

Favorable resuscitation characteristics in patients undergoing extracorporeal cardiopulmonary resuscitation: A secondary analysis of the INCEPTION-trial

  • Johannes F.H. Ubben,
  • Samuel Heuts,
  • Thijs S.R. Delnoij,
  • Martje M. Suverein,
  • Renicus C. Hermanides,
  • Luuk C. Otterspoor,
  • Carlos V. Elzo Kraemer,
  • Alexander P.J. Vlaar,
  • Joris J. van der Heijden,
  • Erik Scholten,
  • Corstiaan den Uil,
  • Dinis Dos Reis Miranda,
  • Sakir Akin,
  • Jesse de Metz,
  • Iwan C.C. van der Horst,
  • Bjorn Winkens,
  • Jos G. Maessen,
  • Roberto Lorusso,
  • Marcel C.G. van de Poll

Journal volume & issue
Vol. 18
p. 100657

Abstract

Read online

Introduction: Extracorporeal cardiopulmonary resuscitation (ECPR) is increasingly used as a supportive treatment for refractory out-of-hospital cardiac arrest (OHCA). Still, there is a paucity of data evaluating favorable and unfavorable prognostic characteristics in patients considered for ECPR. Methods: We performed a previously unplanned post-hoc analysis of the multicenter randomized controlled INCEPTION-trial. The study group consisted of patients receiving ECPR, irrespective of initial group randomization. The patients were divided into favorable survivors (cerebral performance category [CPC] 1–2) and unfavorable or non-survivors (CPC 3–5). Results: In the initial INCEPTION-trial, 134 patients were randomized. ECPR treatment was started in 46 (66%) of 70 patients in the ECPR treatment arm and 3 (4%) of 74 patients in the conventional treatment arm. No statistically significant differences in baseline characteristics, medical history, or causes of arrest were observed between survivors (n = 5) and non-survivors (n = 44). More patients in the surviving group had a shockable rhythm at the time of cannulation (60% vs. 14%, p = 0.037), underwent more defibrillation attempts (13 vs. 6, p = 0.002), and received higher dosages of amiodarone (450 mg vs 375 mg, p = 0.047) despite similar durations of resuscitation maneuvers. Furthermore, non-survivors more frequently had post-ECPR implantation adverse events. Conclusion: The persistence of ventricular arrhythmia is a favorable prognostic factor in patients with refractory OHCA undergoing an ECPR-based treatment. Future studies are warranted to confirm this finding and to establish additional prognostic factors.Clinical trial Registration: clinicaltrials.gov registration number NCT03101787

Keywords